Compare HITI & DHY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | HITI | DHY |
|---|---|---|
| Founded | 2009 | N/A |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Finance/Investors Services |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 220.6M | 240.4M |
| IPO Year | 2021 | 1998 |
| Metric | HITI | DHY |
|---|---|---|
| Price | $2.69 | $15.99 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $4.67 | N/A |
| AVG Volume (30 Days) | 749.3K | ★ 1.0M |
| Earning Date | 09-14-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $27.52 | N/A |
| Revenue Next Year | $10.52 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.02 | $1.61 |
| 52 Week High | $3.80 | $16.67 |
| Indicator | HITI | DHY |
|---|---|---|
| Relative Strength Index (RSI) | 55.89 | 99.08 |
| Support Level | $2.29 | $1.77 |
| Resistance Level | $2.88 | N/A |
| Average True Range (ATR) | 0.12 | 0.16 |
| MACD | -0.00 | 1.44 |
| Stochastic Oscillator | 63.51 | 95.35 |
High Tide Inc is a downstream-focused retailer of cannabis products, distributor, and seller of smoking accessories and cannabis lifestyle products. It is a vertically integrated company in the Canadian cannabis market with various brands in its portfolio such as Canna Cabana, Fastendr, Queen of Bud, Grasscity, Daily High Club, and others. The company's reportable operating segments are: Bricks and mortar, which generates maximum revenue, and E-commerce. Geographically, it derives maximum revenue from its business in Canada, followed by the United States of America, and other international markets.
Credit Suisse High Yield Credit Fund is a diversified, closed-end management investment company. The Fund's principal investment objective is to generate current income. Capital appreciation is a secondary objective, pursued to the extent consistent with the Fund's primary income objective.